2 assets in AA Amyloidosis

Therapeutic assets addressing AA Amyloidosis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Daratumumab AA Amyloidosis	City of Hope Medical Center	P2	B (60)
Melphalan AA Amyloidosis	City of Hope Medical Center	P2	CCC (53)